Why Is Sono-Tek Corporation (SOTK) Stock Down -15.59% Today?
Key Takeaways
- Sono-Tek Corporation (SOTK) shares tumbled roughly 15.59% to about $6.01 in morning trading, down from a prior close of $7.12.
- The selloff followed the release of fiscal second-quarter 2027 results that missed both top- and bottom-line consensus estimates.
- The company reported EPS of $0.02 versus a $0.04 consensus, and revenue of $5.23 million versus roughly $5.56 million expected.
- Management reaffirmed rather than raised its full-year outlook for flat-to-modest revenue growth, disappointing investors who had priced in a re-acceleration.
- The stock had run up toward its 52-week high on medical-device momentum, leaving little room for error heading into the print.
- Traders are now watching whether large clean-energy orders convert to revenue in fiscal 2028 and how second-half growth tracks against guidance.
Opening Summary
Sono-Tek Corporation (SOTK), a Milton, New York-based manufacturer of precision ultrasonic coating systems used across medical devices, microelectronics, alternative energy, and industrial markets, saw its shares fall sharply on Wednesday, October 14. The stock dropped about 15.59%, or roughly $1.11, to around $6.01 in intraday trading, down from a previous close of $7.12. The decline was driven by a fiscal second-quarter earnings miss and management's decision to reaffirm, rather than raise, its full-year guidance, prompting a sharp valuation reset in a stock that had recently traded near its 52-week high.
Earnings Miss Triggers the Selloff
The primary catalyst for the decline was Sono-Tek's fiscal second-quarter 2027 earnings release, covering the three months ended August 31, 2026. The company reported diluted earnings per share of $0.02, missing the analyst consensus of $0.04 by $0.02. Net sales came in at $5.23 million, up about 1% year over year but below the roughly $5.56 million Wall Street had expected. Net income fell to $366,000 from $424,000 a year earlier, as higher operating expenses offset a 7% gain in gross profit.
Despite the miss, the quarter itself was not uniformly weak. Gross margin expanded to 53% from 50% a year ago, and medical-device sales surged 209% to $3.11 million on strong shipments of balloon-coating and specialty stent-coating systems. For the first half of fiscal 2027, medical sales were up 289% to $7.05 million. Yet those bright spots were not enough to satisfy investors who had already bid the stock higher in anticipation of stronger headline numbers.
Reaffirmed Guidance Disappoints a Momentum-Heavy Stock
A second, arguably more important, factor was the company's outlook. Management reaffirmed its prior guidance for flat-to-modest full-year revenue growth, even as first-half revenue advanced 6% and the order book showed momentum. Combined equipment and services backlog rose 23% sequentially to $9.51 million, and the company disclosed roughly $7.19 million in new clean-energy production-system orders expected to ship in fiscal 2028.
The market, however, had been positioned for an upgrade to that outlook. With the stock trading near its 52-week high of roughly $7.48 and carrying a rich valuation relative to its low-single-digit growth target, the reaffirmation signaled that the back half of the fiscal year may be a period of consolidation rather than acceleration. That mismatch between elevated expectations and cautious guidance amplified the post-earnings selling pressure.
Market Context and Trading Activity
The decline reflects a sharp repricing of a small-cap growth story that had enjoyed substantial momentum in recent months. Entering the session, SOTK was up more than 70% over the trailing 12 months and roughly 29% over the prior three months, according to market data, leaving the stock vulnerable to any earnings disappointment. The move lower was driven by company-specific news rather than broad market or sector weakness, and the share-price reaction diverged from the generally stable tone in the wider Nasdaq.
The slide pushed the stock well below the prior session's close and through near-term support levels established during its recent rally toward the $7.40 area. With a market capitalization of roughly $111 million and a debt-free balance sheet holding about $17.7 million in cash, the decline appears rooted in valuation concerns and guidance, not deterioration in the underlying business.
What Comes Next for Sono-Tek Corporation
Looking ahead, investors will focus on whether Sono-Tek can convert its growing backlog — particularly the newly announced clean-energy orders slated for fiscal 2028 — into recognized revenue, and whether second-half growth can exceed the company's conservative full-year target. The medical-device segment, now the clear growth engine, will remain in focus given its triple-digit expansion in the first half.
Key risks include ongoing softness in alternative-energy and electronics/microelectronics sales, which fell sharply in the quarter amid shifting U.S. clean-energy policy and uneven demand. Geographic exposure also remains a factor, with Asia Pacific revenue down 45% in the period. Traders will be monitoring subsequent order announcements, backlog trends, and any updates to guidance in the coming quarters. The company does not currently pay a dividend, and its elevated earnings multiple means the stock may remain sensitive to future guidance changes.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with each bot varying by strategy, timeframe, performance metrics, and the symbols it trades. Only the strongest performers are featured in the Trending AI Robots section, making it a useful starting point for investors exploring data-driven trading tools. Explore the Trending AI Robots page to discover bots that align with your trading style.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SOTK in upward trend: 10-day moving average broke above 50-day moving average on October 02, 2026
The 10-day moving average for SOTK crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 23, 2026. You may want to consider a long position or call options on SOTK as a result. In 79 of 108 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for SOTK just turned positive on September 22, 2026. Looking at past instances where SOTK's MACD turned positive, the stock continued to rise in 36 of 50 cases over the following month. The odds of a continued upward trend are 72%.
SOTK moved above its 50-day moving average on September 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOTK advanced for three days, in 168 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 98 of 131 cases where SOTK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
SOTK broke above its upper Bollinger Band on September 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. SOTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.890) is normal, around the industry mean (4.255). P/E Ratio (39.154) is within average values for comparable stocks, (88.653). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (3.258) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ElectronicEquipmentInstruments
Advertisement